Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice-Reference-Cited by-同舟云学术

Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice

Published:2013-10 Issue:1 Volume:82 Page:31-37
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Yamaguchi Norihiro,VanderLaan Paul A.,Folch Erik,Boucher David H.,Canepa Hannah M.,Kent Michael S.,Gangadharan Sidharta P.,Majid Adnan,Kocher Olivier N.,Goldstein Michael A.,Huberman Mark S.,Costa Daniel B.

Funder

American Society of Clinical Oncology Conquer Cancer Foundation

Lung Cancer Foundation of America-International Association

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. Molecular pathology of lung cancer: key to personalized medicine;Cheng;Mod Pathol,2012

2. Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities;Gaughan;Ther Adv Med Oncol,2011

3. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol,2012